12:00 AM
 | 
May 12, 2014
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Oxford Gene sales and marketing update

Oxford launched its SureSeq Solid Tumor Panel to profile the mutations of patient tumors for 60 cancer-associated genes. The panel,...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >